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Abstract
Background: Mycobacterium indicus pranii (MIP), popularly known as Mw, is a cultivable, non-pathogenic organism, which,
based on its growth and metabolic properties, is classified in Runyon Group IV along with M. fortuitum, M. smegmatis and M.
vaccae. The novelty of this bacterium was accredited to its immunological ability to undergo antigen driven blast
transformation of leukocytes and delayed hypersensitivity skin test in leprosy patients, a disease endemic in the Indian sub-
continent. Consequently, MIP has been extensively evaluated for its biochemical and immunological properties leading to
its usage as an immunomodulator in leprosy and tuberculosis patients. However, owing to advances in sequencing and
culture techniques, the citing of new strains with almost 100% similarity in the sequences of marker genes like 16S rRNA,
has compromised the identity of MIP as a novel species. Hence, to define its precise taxonomic position, we have carried out
polyphasic taxonomic studies on MIP that integrate its phenotypic, chemotaxonomic and molecular phylogenetic
attributes.
Methodology/Principal Findings: The comparative analysis of 16S rRNA sequence of MIP by using BLAST algorithm at NCBI
(nr database) revealed a similarity of $99% with M. intracellulare, M. arosiense, M. chimaera, M. seoulense, M. avium subsp.
hominissuis, M. avium subsp. paratuberculosis and M. bohemicum. Further analysis with other widely used markers like rpoB
and hsp65 could resolve the phylogenetic relationship between MIP and other closely related mycobacteria apart from M.
intracellulare and M. chimaera, which shares $99% similarity with corresponding MIP orthologues. Molecular phylogenetic
analysis, based on the concatenation of candidate orthologues of 16S rRNA, hsp65 and rpoB, also substantiated its
distinctiveness from all the related organisms used in the analysis excluding M. intracellulare and M. chimaera with which it
exhibited a close proximity. This necessitated further analysis of MIP with more sensitive and segregating parameters to
ascertain its precise taxonomic position as a new species. The analysis of MIP and its comparison with other mycobacterial
reference strains based on cellular and biochemical features, growth characteristics and chemotaxonomic studies like FAME
profiling confirmed that MIP is uniquely endowed with diverse metabolic attributes that effectively distinguishes it from all
the closely related mycobacteria including M. intracellulare and M. chimaera.
Conclusion: The results presented in this study coupled with the non-pathogenic nature and different biochemical and
immunomodulatory properties of MIP affirm it as a distinct species belonging to M. avium complex (MAC). It is further
proposed to use an earlier suggested name Mycobacterium indicus pranii for this newly established mycobacterial species.
This study also exemplifies the growing need for a uniform, consensus based broader polyphasic frame work for the
purpose of taxonomy and speciation, particularly in the genus Mycobacterium.
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Introduction
In the late seventies, a Mycobacterium, coded as ‘w’, was selected
by Prof. G. P. Talwar and his colleagues at the All India Institute
of Medical Sciences, New Delhi, from a panel of known atypical
mycobacteria for its ability to evoke cell mediated immune
responses against M. leprae in multibacillary lepromatous leprosy
patients, normally anergic to M. leprae [1]. This Mycobacterium ‘w’,
when used as an adjunct to the standard multidrug therapy against
multibacillary leprosy patients, exhibited a significantly enhanced
bacillary clearance thereby shortening the full recovery time of
patients [2–4]. It has emerged as a powerful immunomodulator in
one of the largest clinical trials in India involving approximately
30,000 household contacts of leprosy patients [5]. ‘Mw’,
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6263commercially available as ‘‘Immuvac’’ vaccine, shares antigens
with M. leprae and M. tuberculosis and provides protection against M.
tuberculosis infection in both BCG responder (Balb/c, C57BL/6
NCrl and C3H/He NCrl) and non-responder (CBA/N) geneti-
cally distinct strains of mice [6,7]. Moreover, a recent study in
mice has confirmed its immunogenicity and protective efficacy
against M. tuberculosis infection in both live as well as heat-killed
form [8]. In the light of its distinctive immunomodultory actions
and a plausible ambiguity of nomenclature with a recently
emerged hyper virulent Beijing strain Mycobacterium tuberculosis
‘W’, it was suggested to use the name Mycobacterium indicus pranii
(MIP) for this bacterium [9].
However, despite the emerging prominence of MIP as a broad-
spectrum vaccine candidate, there have been limited attempts on
its molecular characterization by genotypic analysis barring the
study of a standard gene locus hsp65 [10]. With the advent of new
sequencing technologies and better culture techniques, there has
been an increased awareness about the diversity within the
microbial world, especially in genus Mycobacterium. Consequently,
many new species have recently been notified that share nearly
100% similarity with the characteristic molecular signatures of
MIP [11–13]. Since such an extreme sequence conservation at
species level is well documented in the case of Mycobacterium,
further analysis of MIP would be sagacious to have an explicit
understanding of taxonomic identity and specific physiological
attributes of this bacterium, particularly in the context of evolution
and speciation. For this, extensive polyphasic taxonomic studies
were undertaken pertaining to its phenotypic (size, type and
morphology), chemotaxonomic (whole cell fatty acid analysis),
molecular (presence or absence of genomic markers) and
phylogenetic characterization based on concatenation of repre-
sentative orthologues of MIP like 16S rRNA, hsp65 and rpoB,
which have been widely used for species differentiation studies in
mycobacteria [14]. Here, we describe the results of these studies,
evaluate these findings in the light of taxonomy and evolution of
mycobacteria and define the precise taxonomic position of MIP as
an independent species belonging to M. avium complex.
Results
Purity of culture, colony morphology and molecular
identity
The growth of MIP on Middlebrook (MB) 7H11 agar as
uniform colonies indicated the purity of the culture. The colonies
were 1–2 mm in size, smooth, convex, monotypic, raised, shiny,
round and nonpigmented. They were not arranged in any definite
pattern. No cording was observed. Molecular identity of MIP was
established by PCR amplification of hsp65 gene with MIP genomic
DNA as template. A ,440 bp amplicon with MIP specific
nucleotide substitutions at positions 94, 121, 130 and 286 bp
authenticated the strain used in this study [10]. These substitutions
rendered it distinct from M. tuberculosis H37Rv, M. bovis, M. bovis
BCG, M. leprae, M. avium, M. intracellulare, M. scrofulaceum, M.
paratuberculosis, M. kansasii, M. gastri, M. gordonae, M. shimoidei, M.
malmoense, M. haemophilum, M. nonchromogenicum, M. trivale, M.
marinum, M. flavescens, M. simiae, M. sculgai, M. xenopi, M. asiaticum,
M. aurum, M. smegmatis, M. vaccae, M. fortuitum, M. chelonae and M.
abscessus [10].
Growth pattern and biochemical features
MIP showed no apparent growth on nutrient and MacConkey
agar; however, the growth on Lowenstein Jensen (LJ) slant was
observed in 4–6 days. On MB7H11 agar, MIP colonies appeared
in between 6–8 days. It did not produce any pigment either in light
or dark. Apparently, MIP grows relatively faster, when compared
to M. tuberculosis (.3 weeks), M. seoulense (.3 weeks), M. arosiense
(.3 weeks), M. bohemicum (4–6 weeks) and the members of MAC
complex like M. intracellulare, M. avium subsp. hominissuis, M. avium
subsp. paratuberculosis and M. chimaera (.2 weeks) [11–13,15,16].
However, when compared to usual fast growers, such as M.
smegmatis (,2 days), M. pheli (,5 days) and M. vaccae (,5 days),
MIP actually grows considerably slowly notwithstanding its several
characteristics usually associated with rapid growers such as the
ability to grow in 5% NaCl (Table 1) [17]. The growth curve
analysis of MIP in MB7H9 broth revealed that it reached a
saturation phase in 8 to 10 days (Figure 1). There was no apparent
difference in growth and colony forming time of MIP at 30uC and
37uC on MB7H11 agar. However, in broth culture (MB7H9), it
grew faster at 37uC and reached the saturation phase earlier in
comparison to 30uC inspite of a relatively prolonged lag phase.
MIP has been predicted to be a fast grower based on its growth on
LJ medium, Dubos agar and in Sauton’s medium [18,19]. Thus,
MIP seems to share properties which are exclusive to either slow
growers or fast growers reflecting upon its unique position,
wherein it grows faster than the typical slow growers belonging to
MAC and slower in comparison to classical fast growers belonging
to Runyon Group IV like M. smegmatis. Thus, MIP could be
differentiated from the members of MAC by virtue of its faster
growth rate and colony forming time on MB7H11 agar.
Biochemically, MIP was negative for niacin test, Tween 80
hydrolysis and urease production and positive for semi quantitative
catalase and heat resistant catalase, tellurite reduction and for
sodium salicylate degradation [18,19]. MIP could grow at 25uC
and 45uC and was found to be resistant to isoniazid (10 mg/ml).
Besides, the bacillus could reduce nitrates to nitrites and could also
utilize sodium nitrate and sodium nitrite as nitrogen sources. The
organism did not grow on fructose and arabinose as the only
source of carbon. The detailed biochemical properties of MIP and
their comparative analysis with related mycobacteria are depicted
in Table 1.
Molecular and phylogenetic analysis of MIP reveals its
proximity with opportunistic mycobacteria of M. avium
complex
The BLAST based similarity searches of 16S rRNA of MIP with
nr (non-redundant) database at NCBI (http://blast.ncbi.nlm.nih.
gov/Blast.cgi), revealed a similarity of $99% displaying very
limited mismatches with M. intracellulare (0.07%), M. arosiense
(0.34%), M. seoulense (0.68%), M. avium subsp. hominissuis (0.75%),
M. avium subsp. paratuberculosis (0.75%), M. chimaera (0.9%) and M.
bohemicum (0.9%). All of these mycobacteria belong to MAC group
of organisms except M. bohemicum and M. seoulense, which are closer
to M. scrofulaceum and M. kansassi [11]. To further discriminate MIP
from rest of the species, two widely used molecular chronometers
namely, rpoB and hsp65 were also evaluated [20,21]. It has been
reported that a sequence similarity of complete rpoB gene ,97.7%
correlates with an ANI (average nucleotide identity between two
organisms) value of ,94.3% and DDH (DNA: DNA Hybridiza-
tion) value of ,70%, which are the taxonomic benchmarks to
assign species status with respect to intraspecies comparisons [22].
The comparison of MIP rpoB gene with corresponding orthologues
from completed mycobacterial genome sequences revealed a
percentage nucleotide similarity of 96% with M. avium subsp.
hominissuis, 95% with M. avium subsp. paratuberculosis followed by
91% with M. marinum, thereby establishing the distinctiveness of
MIP from M. avium subsp. paratuberculosis and M. avium subsp.
hominissuis (Supplementary Figure S1). With M. intracellulare, M.
chimaera, M. bohemicum, M. arosiense and M. seoulense, the percentage
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92%, respectively on comparison of their partial rpoB sequences,
while a similarity of 99.7%, 98.8%, 93%, 95% and 95%,
respectively was observed on comparing with corresponding
hsp65 sequences. The phylogenetic analysis involving MIP, all
known members of M. avium complex along with environmental
mycobacteria using concatenated loci of 16S rRNA, hsp65 and
rpoB genes as genotypic markers effectively showed that MIP was
distinct from all other members of MAC except M. intracellulare and
M. chimaera with which it showed an apparent proximity (Figure 2).
These observations substantiated the importance of these
genotypic markers in phylogenetic studies; nonetheless, the very
few substitutions exhibited by these marker genes pointed out the
need for more segregating parameters to further delineate the
heterogeneity in MAC.
Chemotaxonomic investigations reveal MIP to be
different from all known members of MAC including
M. intracellulare and M. chimaera
Chemotaxonomic investigations by FAME analysis have often
played a cardinal role in resolving inadvertencies in case of
Figure 1. Growth rate analysis of MIP: MIP was cultured in MB7H9-ADC medium at 30uC and 37uC. The A600nm of liquid culture of MIP was plotted
against time to analyze the pattern of MIP growth. Growth was monitored by measuring the change in the value of A600nm over time. Each
experiment was performed with replicates and error bars for each time point are shown. A typical growth curve with three distinct phases was
generated with culture becoming saturated in 8 to 10 days.
doi:10.1371/journal.pone.0006263.g001
Figure 2. Phylogenetic positioning of MIP: The Phylogenetic positioning of MIP with respect to other members of genus Mycobacterium was
performed by making concatenated tree of 16S rRNA, rpoB and hsp65 involving members of MAC and other environmental isolates, which are close
to MIP. The alignment was carried out using clustal x ver 1.81[50] and a phylogenetic tree rooted to M. malmoense was constructed using Neighbor
joining (NJ) method with 1,000 bootstrap iterations [51].
doi:10.1371/journal.pone.0006263.g002
Species Status for MIP
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to Mycobacterium as it examines the features at whole organism level
[23,24]. FAME (fatty acid methyl ester) analysis is a very sensitive
approach, which proficiently reflects on biochemical and physio-
logical attributes of an organism to correctly define its precise
taxonomic position [25–27]. Hence, we analyzed MIP for the
presence of FAME and compared it with the fatty acid profiles of
other mycobacteria (Table 2). This comparative analysis demon-
strated the predominant fatty acids of MIP as summed feature III
that corresponds to 20:0 alcohol/19:0 cycloprop v10c and/or
19:0 cycloprop v8c, comprising 67.25% of total fatty acids content
analyzed. Summed feature II comprised of 13.89% of total fatty
acids content analyzed and corresponds to 17:1 v7c/18: 0
alcohol/17:1v6c/17: cyclopropane. Similarly, summed feature I
was represented by ,1% of total fatty acids content analyzed and
comprised of 8-Me-16:0/10-Me-16:0 as given in Table 2. Thus,
MIP could be distinguished from M. intracellulare not only by the
presence of a higher fraction of fatty acid content as summed
features but also by the presence of 18:1 v7c (1.37%) and the
absence of 20:0 fatty acids (Table 2). Similarly, M. chimaera could
be typified by the relative preponderance of 18:1 v9c (18.68%)
and presence of 16:1 v10c (5.29%), which is absent in MIP [17].
The comparative FAME analysis, thus, confirmed that MIP
harbors unique metabolic machinery, which differentiates it
significantly from all other mycobacteria used in this study
including M. tuberculosis, M. avium, M. intracelluare, M. chimaera, M.
arosiense, M. seoulense on the basis of biochemical parameters.
Further analysis of MIP based on the measurement of evolutionary
distance by using the FAME mycobacterial library (MIDI
Sherlock, USA, which matches the sample’s composition with
the stored FAME patterns of various mycobacterial species to
provide a relative distance from the ‘‘mean’’ of fatty acid
population of the sample) showed MIP to be nearest to M.
scrofulaceum (Distance=21.095), followed by M. aurum (Dis-
tance=32.03) and M. fortuitum (Distance=84.4). It is noteworthy
here that M. aurum and M. fortuitum are fast growers while M.
scrofulaceum is classified as a slow growing organism.
Discussion
The classification of organisms into species with shared traits and
niche preferences constitutes the cornerstone of the microbial world
and is fundamental to efficiently organize and disseminate informa-
tion about microbial diversity. The determination of molecular
sequences and the understanding that they could be employed to
differentiate organisms have revolutionized the perception of
microbial diversity. The advent of new sequencing and culture
methods has led to the identification of many new strains and
availability of sequencing data of their marker genes. While this has
made identification of new species easier in some cases, the
consideration of arbitrary cutoff values based on similarity in selected
genes like 16S rRNA (presently99% with16S rRNA) as a yardstick to
confer species status may sometimes be fraught with the danger of
losingoutonmicrobialdiversity.Aphylogenetictreeconstitutedfrom
a set of genes essentially infers evolutionary histories of these genes,
which may not necessarily reflect on the descent of species [28]. This
observation is especially more relevant in case of organisms belonging
to genus Mycobacterium which are clonal in nature and have very
restricted nucleotide substitution rates [29].
With comparison of 16S rRNA gene, an extremely powerful
tool and by far the single most common molecular technique
Table 2. Comparative analysis of MIP with other related mycobacteria by FAME.
Sr.
No.
Feature
Name M. bohemicum M chimaera MIP M. intracellulare M. scrofulaceum M. aurum M. fortuitum M. tuberculosis M. avium
1 12:0 - 0.24 0.12 - - - - - -
2 14:0 2.55 7.43 3.5 4.69 4.44 5.93 7.1 1.33 3.6
3 15:0 0.53 0.49 0.8 0.58 0.46 - 0.55 0.53 0.6
4 16:0 26.93 24.10 4.68 35.32 36.32 30.12 43.54 39.21 34.98
5 17:0 0.52 0.30 - - 0.5 - 0.52 2.45 -
6 18:0 3.46 2.27 0.21 4.48 7.19 2.66 4.43 10.6 3.98
7 10Me-18:0
TBSA
7.48 8.26 1.75 13.28 6.3 9.09 14.35 19.79 13.31
8 20:0 0.67 0.52 - 0.6 0.85 2.23 0.63 1.16 0.47
9 16:1 v6c - - 3.04 7.23 6.06 5.58 7.46 3.41 6.43
10 16:1 v7c 2.15 1.62 0.45 1.64 1.56 - 0.52 - 1.38
11 16:1 v9c 1.60 1.54 0.27 0.71 0.57 2.19 0.65 - 1.08
12 18:1 v7c - - 1.37 - - - - - -
13 18:1 v9c 24.42 18.68 2.44 17.52 21.1 27.35 19.25 19.71 19.38
14 *Summed
Feature I
- - 0.24 0.78 - - 0.62 0.53 0.64
15 *Summed
Feature II
- - 13.89 3.01 5.76 10.01 - - 1.75
16 *Summed
Feature III
- - 67.25 9.98 8.56 3.74 - - 12
The FAME profile for MIP was generated by using Gas Liquid Chromatography and compared with the profiles of other mycobacteria in the FAME database of Microbial
Identification System (MIDI, Inc., Newark, Del.).Values represent percentage amount of total fatty acids. [*Summed features consist of one or more fatty acids that could
not be separated by the Microbial Identification System. Summed feature III: 20:0 alcohol/19:0cyclopropv10cand/or 19:0 cycloprop v8c; Summed feature II: 17:1 v7c/
18:0 alcohol/17:1v6c/17: cyclopropane; and summed feature I: 8-Me-16:0/10-Me-16:0; TBSA- Tuberculostearic acid].
doi:10.1371/journal.pone.0006263.t002
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greater than 99% similarity with M. intracellulare, M. arosiense, M.
seoulense, M. chimaera, M. avium, subsp. hominissuis, M. avium subsp.
paratuberculosis and M. bohemicum. However, the maximum
proximity was apparent with M. intracellulare and M. chimaera and
was marked by extreme conservation (.99%) even on comparison
of other genotypic markers, such as rpoB and hsp65. This gives the
impression that MIP is related to these strains or is a derivative or
sequevar of M. intracellulare, which appears to be inaccurate in the
backdrop of the scientific evidence presented in this study. M.
intracellulare besides being a known pathogen and a slow grower
also does not grow in 5% NaCl. Unlike MIP, M. intracellulare does
not reduce nitrate, a trait that it shares with M. avium, M. chimaera
and M. scrofulaceum [12]. Similarly, M. arosiense, despite having
extremely limited divergence with MIP on comparison of its
marker genes used in this study, is a pathogenic scotochromogen
that grows optimally at 42uC and takes more than 14 days for
visible colonies to appear on 7H11 agar, that too with a heavy
inoculum [12]. Thus, it is quite perspicuous that MIP harbors
different biochemical traits from the organisms, which appear to
be its close relatives on the basis of phylogenetic analysis based on
marker genes (Table 1).
However, since based on the phylogenetic markers, the
similarity ascertained between different orthologues was close to
100%, it was also evident that more sensitive and differentiating
parameters would be required, if we have to further ascertain the
significance of these small differences observed in the phylogenetic
comparisons. Hence, as a next step, the FAME analysis of MIP
was carried out. It offered the obvious advantages that: i) FAME
analysis reflects on the biochemical and physiological attributes of
the associated organisms rather than on the mutations in the genes
encoding the candidate orthologues in order to correctly define
their precise taxonomic position; and ii) it offers a highly
reproducible value based on the comparisons with other members
of the genus [23,24]. Its significance became apparent, when the
FAME profile of MIP was compared with its counterparts from
several other members of family Mycobacteriaceae. The FAME
pattern for MIP is different from M. intracellulare, M. arosiense and
M. chimaera, the organisms closest to MIP on the basis of
comparison of 16S rRNA sequence (Table 2). Incidentally, M.
intracellulare and M. arosiense share a similar FAME profile marked
by predominance of 16:0, 10-methyl 18:0 TBSA (tuberculostearic
acid) and 18:1 v9c as major fatty acids and can not be
differentiated exclusively on the basis of FAME analysis [12].
However, it became clear that MIP possessed a FAME profile that
was visibly distinct from the rest of the organisms available in
FAME database although it showed certain proximity with M.
scrofulaceum followed by fast growing M. aurum, M. fortuitum and
other rapid growers (Table 2). From these observations, it was
obvious that MIP possesses unique pathways of fatty acid synthesis
probably reflecting on its need for a saprophytic life style. It is
noteworthy here that lipids and fatty acids are known to have
immunomodulatory activity [30,31]. Besides, they are also
involved in stimulation of cytokine production, proliferation of
human T lymphocytes and in the activation of protein kinases
[32]. It is tempting to speculate the role of these novel fatty acids in
the immunomodulatory activity of MIP although this merits
specific immunological investigations.
An important insight emerging from the above discussion is that
reliance on a single identification system, whether phenotypic,
genotypic or chemotaxonomic, may not be appropriate and can
undervalue the microbial diversity thereby defying the overall
rationale of taxonomy. This point bears special relevance in the
case of genotypic taxonomy, which is based on the application of
conserved housekeeping genes as markers. The usage of candidate
marker genes in taxonomy is underpinned with a notion that these
genes may correctly represent the entire genomic complexity of
the species and hence can be good surrogate to define the species.
However, it is being increasingly realized that this notion may not
be absolutely correct [33,34]. This point is specifically more
pertinent in the case of mycobacteria, which are organisms of high
biomedical prominence that share a similarity up to 99.95% even
at the comparison of their whole genome sequences [35]. The
literature is replete with the reports of mycobacteria which have
been assigned the species status despite sharing almost 100%
similarity in their marker genes [33,36]. 16S rRNA gene, which
has been preeminent in the advancement of bacterial taxonomy
and has been the most widely used marker, reveals an identity of
100% (M. kansasii and M. gastri), 99.9% (M. malomense and M.
szulgai) and 99.9% (M. microti and M. bovis), on its comparative
analysis between mycobacterial species. The analysis of two other
extremely popular genotypic markers hsp65 and rpoB revealed a
similarity of 99.5% and 99.6%, respectively between M. marinum
and M. ulcerans and 99.5% and 99.9%, respectively between M.
intracellulare and M. chimaera. M. chimaera in fact shows 100%
similarity with M. intracellulare serovars type 7, although it is a
distinct species. Thus, the resolution of these markers has been
further compromised because of the heterogeneity in M. avium
complex. Nonetheless, the species status has been accorded in
these cases based on the mounting recognition that microbial
diversity in the context of speciation essentially implies a defined
ecological niche in terms of its life style, role in ecosystem and host
preference with a shared phylogenetic heritage [37].
For a niche specific adaptation, a microbe may accentuate
certain changes in its genic repertoire by undergoing substitutions
in pre-existing genes, losing certain genes detrimental to a specific
lifestyle, by undergoing recombination events or else by acquiring
genes via lateral transfer events. In our earlier studies, we have
established an important paradigm with respect to M. avium
complex that pathogenic adaptations in MAC, unlike in the
organisms of M. tuberculosis lineage, are not exclusive to the
selective deletion events as shown by a congruent RD (region of
deletions) profile across the pathogenic and saprophytic lineage of
genus Mycobacterium [38]. Rather it is the selective acquisition of
genes in MAC organisms that has helped in fine-tuning their fitness
for a wide range of habitats and hosts to undergo an intracellular
life style [38]. It appears that subsequent recombination events in
M. avium lineage might have also played a key role in generating
the antigenic diversity required for the differential display of
pathogenicity and host range among different species. This was
substantiated by our observations during analysis of DT1
(gb|L04543.1|) and DT6 (gb|L04542.1|), the genomic markers
specific for M. intracellulare and M. avium lineage, respectively, for
their presence and organization in MIP and other closely
associated mycobacteria [39]. Interestingly, in MIP, which is the
progenitor of MAC organisms [38], while the DT1 locus was
present and organized in an uninterrupted manner, the presence
of DT6 was marked by an intrusion comprised of a .2.1 kb
genomic fragment (Supplementary Figure S2). However, this locus
of .2.1 kb has regained a new position adjacent to DT6 in both
M. avium subsp. paratuberculosis and M. avium subsp. hominissuis,
albeit in opposite orientation (reverse complemented) to each
other, as depicted in supplementary figure S2. It is noteworthy that
this region apparently lacks any mobile element - like insertional
elements or transposons thereby strongly pointing towards the role
of putative recombination events in speciation in the MAC
organisms. Thus, it can be concluded that speciation in M. avium
complex is a direct function of genome plasticity [40] and results
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recombination events.
MAC is comprised of M. avium (with four subspecies namely M.
avium subsp. avium, M. avium subsp. paratuberculosis, M. avium subsp.
silvaticum and M. avium subsp. hominissuis), M. intracellulare, M.
chimaera, M. colombiense and a recently emerged M. arosiense [12].
These organisms have a diverse host range and are mainly
responsible for infections in ruminants and birds besides causing
‘opportunistic’ infections in immune compromised humans and in
nosocomial settings. This group of organisms possesses extreme
sequence homogeneity in their marker genes and also shares
almost similar biochemical properties thereby making it exigent to
differentiate them by biochemical characteristics. M. avium and M.
intracellulare were universally identified and distinguished by the
ability of M. intracellulare to cause virulence in chicken [41], thus
illustrating their different immunological attributes and distinct
niche preferences. Similarly, MIP is also defined by virtue of its
unique immunological features owing to which it has been used as
a commercial therapeutic vaccine against leprosy and extensive
clinical trials for its efficacy against many dreaded infections and
diseases like cancer [42,43], HIV [44] and tuberculosis [7,45] are
ongoing. MIP reportedly does not cause any infection in mice,
guinea pigs and monkeys, the animal models in which it has been
tested, thus, suggesting of a saprophytic lifestyle for this bacterium
[46]. Thus, MIP is distinctly different from the members of MAC
including M. intracellulare on the basis of its unique properties as
described in this study (Table 3). Moreover, analysis of a draft MIP
genome (Saini V, Raghuvanshi S, Ahmed N et al., unpublished)
indicated an average GC (G+C) content of ,68.0% for MIP,
which differs considerably from that of M. avium subsp.
paratuberculosis (69.30%), M. avium subsp. hominissuis (69.0%), M.
avium subsp. avium (69%, ACFI00000000) and that of M.
intracellulare (67%, ABIN00000000). The genomic GC content
constitutes an important paradigm in prokaryotic evolution and is
critical for taxonomic analyses [47]. The deviations of more than
1% in total GC content of MIP both from M. avium lineage
organisms and M. intracellulare reaffirms its distinctiveness from
these organisms belonging to MAC. Hence, MIP should be
assigned an appropriate taxonomic status as a distinct species
belonging to MAC. Additionally, the comparative evaluation of
genome size of MIP with that of M. avium subsps. paratuberculosis
(4.82 Mb), M. avium subsps. avium (4.85 Mb), M. avium hominissuis
(5.47 Mb) and M. intracellulare (5.32 Mb) revealed that MIP has a
larger genome size (Saini V, Raghuvanshi S, Ahmed N et al.,
unpublished).
These observations, in the light of the non-pathogenic nature of
MIP coupled with our detailed genome wide studies, demonstrate
that MIP indeed is a distinct and unique organism belonging to
MAC. The growth pattern of MIP exhibited a growth rate that was
faster than the typical slow growers such as M. tuberculosis and
slower in comparison to typical fast growers, such as M. smegmatis,
thus placing MIP more or less equidistant from the slow and fast
growers belonging to genus Mycobacterium. It is noteworthy here
that, in mycobacteria, fast growers normally represent non-
pathogenic organisms while slow growers are usually specialized
pathogens. The FAME analysis of MIP and its comparison with
the fatty acid complement from other mycobacterial species also
substantiates the placement of this saprophyte in between fast and
slow growers. Thus, it appears that MIP represents an organism in
evolutionarily transitory position with respect to a fast grower and
a slow grower, a fact also reflected upon by ‘low - resolution’ of
phylogenetic signals in terms of its segregation from other closely
related species. Thus, MIP may effectively demarcate the
boundaries between a philanthropic vaccine strain and seasoned
pathogens like opportunists of the MAC lineage. The novelty of
MIP established in this study provides a categoric evidence to
formally endorse the earlier proposed name M. indicus pranii for this
newly established mycobacterial species [9]. Hence, in future, it
should be designated as Mycobacterium indicus pranii in the relevant
databanks. The unraveling of this organism’s genomic blueprint
would help in understanding the evolutionary events that underpin
the circuits of growth and virulence optimization in the genus
Mycobacterium.
This study highlights that the taxonomic categorization in genus
Mycobacterium is intricate and difficult to disentangle from rest of
the taxa. The species boundaries in this genus may not be
circumscribed to few changes in housekeeping genes which have a
variable rate of substitution and are, often, non adequately
sensitive and specific to encompass all the evolutionary events in
the realms of speciation as highlighted in the present work. A
uniform and consensus derived polyphasic framework based on
phylogenetic, biochemical and chemotaxonomic investigations is
proposed for resolving such prevalent heterogeneities in myco-
bacteria.
Species Description for M. indicus pranii
(DSM 45239
T=MTCC 9506
T)
M. indicus pranii (MIP) is a cultivable, non-pathogenic sapro-
phytic organism, which belongs to Runyon group IV based on its
growth and biochemical characteristics, summarized in table 1. It
gives a smooth and round colony type (on the entire margin), size
1–2 mm and can be grown at 25uCt o4 5 uC on Lowenstein
Jensen, Dubos and MB7H11 agar, 5% NaCl and 10 mg/ml
isoniazid [19]. It does not produce any pigment either in light or
dark. It was found to be negative for niacin test, positive for
tellurite reduction, negative for Tween 80 hydrolysis as well as
Table 3. Comparative analysis of various taxonomic attributes of MIP vis-a `-vis other members of MAC.
Mycobacterial species
Phylogenetic
attributes Genomic attributes
Biochemical
attributes
Nature of
organism
Size (Mb) G+C content (%)
M. avium subsp. paratuberculosis Different 4.8 69.3 Different Pathogenic
M. avium subsp. hominissuis Different 5.4 69.0 Different Pathogenic
M. intracellulare Similar 5.3 67.0 Different Pathogenic
MIP - .5.5 ,68.0 - Saprophytic
MIP can be distinguished from all the members of M. avium complex owing to its different phylogenetic, biochemical, immunological and genomic features. However,
in case of M. intracellulare, phylogenetic analysis based on marker genes does not have sufficient resolution to differentiate it from MIP.
doi:10.1371/journal.pone.0006263.t003
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on fructose or on arabinose as the only source of carbon. It differs
significantly from slow growers such as M. tuberculosis, M.
intracellulare, M. avium, M. chimaera and also from fast growers like
M. fortuitum, M. chelonae, M. smegmatis and M. vaccae based on a
profiling of its biochemical properties. MIP can be typified by a
summed feature III that corresponds to 20:0 alcohol/19:0
cycloprop v10c and/or 19:0 cycloprop v8c, comprising 67.25%
of total fatty acid content analyzed, a summed feature II, which is
comprised of 13.89% and consists of 17:1v7c/18: 0 alcohol/
17:1v6c/17: cyclopropane, and a summed feature I, which
represents ,1% of total fatty acid analyzed and constitutes of 8-
Me-16:0/10-Me-16:0. MIP could be differentiated from other
mycobacteria by the presence of fatty acids like 18:1v7c (1.37%)
and absence of 20:0 fatty acids. With a GC content of ,68%, it
differs significantly from its nearest phylogenetic relatives of MAC
and also has a considerably larger genome size as compared to M.
tuberculosis, M. avium subsp. hominissuis, M. avium subsp. paratuber-
culosis, and M. intracellulare. The phylogenetic analysis has
established MIP as the predecessor of MAC complex [38]. The
type species of MIP is DSM 45239
T=MTCC 9506
T.
Materials and Methods
DNA isolation and strain authentication
MIP was received on LJ slant as a kind gift from Dr. Rajni Rani,
National Institute of Immunology, New Delhi. The culture was
streaked on MB7H11 agar supplemented with 1X OADC (Oleic
acid Albumin Dextrose Catalase) as well as on LB (Luria Bertani)
agar to check for any contaminating bacteria. Once the purity of
the culture was confirmed, it was inoculated into MB7H9 medium
and the genomic DNA was isolated. Briefly, MIP culture (100 ml)
was grown to an absorbance of 1.5 at 600 nm (A600nm) in MB7H9
medium supplemented with 0.5% glycerol, 0.2% Tween-80 and
1x ADC (albumin dextrose catalase) at 37uC in an orbital shaker at
200 rpm followed by incubation with glycine (1%) at 37uC for
24 hrs. After 24 hrs of the addition of glycine, cells were harvested
by centrifugation at 8,000 rpm for 10 min at room temperature
and were lysed by incubating first with 5 ml lysis buffer, TEG (Tris
EDTA glucose) containing 500 ml lysozyme (20 mg/ml) at 37uC
for 16 hrs followed by incubation with 1 ml SDS (10%) and 500 ml
proteinase K (10 mg/ml; Sigma) at 55uC for 40 min with
intermittent gentle swirling. The lysate was incubated with 2 ml
of NaCl (5 M) and 1.6 ml of CTAB (cetyl trimethyl ammonium
bromide) at 65uC for 10 min. Genomic DNA was extracted with
phenol (pre-equilibrated with Tris-HCl, pH 8.0) and chloroform
(1:1) [twice] followed by chloroform extraction [twice]. DNA in
the aqueous phase was precipitated by incubation with 0.6 v/v
isopropanol at room temperature for 15 min. The genomic DNA
spool was removed by using a sterile microtip washed with 70%
ethanol, air dried and resuspended in 200 ml autoclaved double
distilled water and kept at 4uC for the proper resuspension of
DNA.
To ascertain the authenticity of the strain, MIP was tested for
the presence of unique nucleotide substitutions reported for its
hsp65 gene [10]. The primers Tb11 (59-accaacgatggtgtgtcc-39) and
Tb12 (59-cttgtcgaaccgcatacct-39) were used to amplify hsp65 by
PCR using MIP genomic DNA as template. Briefly, amplification
reaction contained 50 ng of template DNA, 1x Taq polymerase
buffer, 200 mM each of deoxynucleotide triphosphates (dNTP),
and 1 ml of 20 pm/ml each of the primers, 1.5 mM MgCl2 and 2
U of Taq polymerase (NEB, UK). The amplification reaction
comprised of initial denaturation at 94uC for 5 min, thirty cycles of
denaturation at 94uC for 1 min, annealing at 55uC for 2 min and
an extension at 72uC for 2 min followed by a final extension at
72uC for 10 min.
Growth rate analysis
MIP was grown on nutrient agar, MacConkey’s agar, LJ slant
and OADC supplemented MB7H11 agar. MIP was evaluated for
colony forming time on MB7H11 agar. It was also grown in
MB7H9 broth supplemented with 1XADC and 0.2% Tween 80 as
mentioned earlier. For all purposes, A600nm was measured at
appropriate time points throughout the growth of the 100 ml
culture. Briefly, small aliquots of the culture (0.1 ml) were removed
aseptically; diluted to 1:10 with MB7H9 supplemented with 0.2%
(v/v) Tween 80-1XADC and the A600nm was measured. The
A600nm of MIP cultures were plotted against time, and a typical
growth curve was generated. However, the members of MAC are
known to grow optimally at 30uC [48]. Considering the proximity
of MIP with MAC, MIP was also evaluated for its growth at 30uC.
Phenotypic, Biochemical and chemotaxonomic analysis
MIP colonies were physically examined for their type,
appearance, and morphology and pigment production. The
culture features like growth at 25uC, 37uC and 45uC, pigment
production, tolerance to NaCl, resistance to isoniazid were
examined using standard lab procedures [49]. Whole-cell fatty
acid analysis was performed by Gas Liquid Chromatography using
profiles in the Microbial Identification System [26] (MIDI Inc.,
Newark, Del.). Mycobacterial cells were grown and harvested
according to the manufacturer’s protocols (MIDI Inc., Newark,
Del.). Peaks were integrated automatically and fatty acid names
and percentages were determined using the MIDI software
package provided by manufacturers. This tool also generated
distance values from the nearest organisms based on the
comparison of fatty acid profiles stored in MIDI database. GC
content was calculated from the whole genome data of MIP by
using indigenously developed perl scripts.
Molecular taxonomy, phylogenetic analysis and
sequence submission
MIP genes encoding for 16S rRNA, hsp65, rpoB, DT1 and DT6
have been sequenced and retrieved as reported elsewhere [38].
The gene sequences corresponding to the relevant orthologues in
other mycobacterial organisms were retrieved from NCBI (ftp://
ftp.ncbi.nih.gov/genomes/Bacteria/). Similarity searches of cur-
rent nucleotide databases were carried out with the network
service of the National Center for Biotechnology Information
(http://www.ncbi.nlm.nih.gov) with the BLAST algorithm and
percentage mismatch in 16S rRNA, hsp65 and rpoB sequences was
inferred. Percentage mismatch was calculated as number of total
mismatches/length of alignment into hundred. To construct
phylogenetic tree, the sequences were downloaded from the gene
databanks, concatenated and aligned with clustalx ver.1.81 [50]. A
phylogenetic tree rooted to M. malmoense was constructed using
Neighbour joining (NJ) method with 1,000 bootstrap iterations
[51]. MIP sequences used in this study have been deposited to gene
databanks under various accession numbers 16S rRNA
(DQ437715), hsp65 (DQ437718), rpoB (DQ437721) and the locus
encompassing DT6 region (FJ970491).
Culture deposition
MIP has been deposited at MTCC, IMTECH, Chandigarh,
India (accession no. MTCC 9506
T) and at DSMZ (German
Collection of Microorganisms and Cell Cultures, Braunschweig,
Germany; accession no. DSM 45239
T).
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Figure S1 Sequence Alignment of complete rpoB gene of MIP:
The comparative analysis of rpoB of MIP reveals that it shares a
homology of 96%, 95% and 91% with M. avium subsp. hominissuis
(MAH), M. avium subsp. paratuberculosis (MAP) and M. marinum
(MMAR), respectively. This suggests that MIP is distinct from other
mycobacterial species used in this analysis [22]. The sequences
were aligned with clustal x ver 1.81[50] and alignments were
edited using Jalview [52]. The major regions of divergence have
been boxed and are indicated by arrow marks.
Found at: doi:10.1371/journal.pone.0006263.s001 (2.94 MB TIF)
Figure S2 Genomic organization of DT6 (the genomic marker
specific for M. avium lineage): The analysis of DT6 in MIP and
associated organisms for its presence and organization revealed
that this region was marked by an intrusion comprised of a
.2.1 kb genomic fragment in MIP, the progenitor strain of MAC
lineage (38). However, this locus of .2.1 kb has regained a new
position adjacent to DT6 in both M. avium subsp. paratuberculosis
and M. avium subsp. hominissuis, albeit in opposing orientation,
suggesting thereby of a putative recombination event (see the
orientation and change in the sequence arrangement on the locus).
The dotted lines depict the recombination within DT6 region
while the straight lines show the arrangement of .2.1 kb region in
these species of MAC.
Found at: doi:10.1371/journal.pone.0006263.s002 (0.16 MB TIF)
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